Table 3.
Assay results of the drugs predicted by AI Model 2.
| AI predict drugs | Concentration (μM) |
|
|---|---|---|
| Cytotoxicity | Viral Inhibition | |
| ABT-199 | >2 | NA |
| Baricitinib | >50 | >50 |
| Bifonazole | >10 | NA |
| Celecoxib | ≧50 | 50 |
| Chlorothiazide | >50 | >50 |
| Clorsulon | >50 | >50 |
| Dapsone | >50 | >50 |
| Dihydroergotamine | >50 | >50 |
| Dolasetron | >50 | >50 |
| Eletriptan HBr | >50 | >50 |
| Eptifibatide | >50 | >50 |
| Etodolac | >50 | >50 |
| Fenbufen | >50 | >50 |
| Flufenamic acid | >50 | >50 |
| Fomepizole | >50 | >50 |
| Histamine | >50 | >50 |
| Hydrochlorothiazide | >50 | >50 |
| Indapamide | >50 | >50 |
| Naratriptan | >50 | >50 |
| Nimesulide | >50 | >50 |
| Nitazoxanide | >10 | NA |
| Nitisinone | >50 | >50 |
| Quinapril | >50 | >50 |
| Rizatriptan | >50 | >50 |
| Ruxolitinib | >10 | NA |
| Serotonin | >50 | >50 |
| Sorafenib | >50 | >50 |
| Sumatriptan | >50 | >50 |
| Tadalafil | >50 | >50 |
| Thiabendazole | >50 | >50 |
| Tofacitinib | >50 | >50 |
| Tolcapone | >50 | 50 |
| Trichlormethiazide | >50 | >50 |
| Triclabendazole | >2 | NA |
| Triflusal | >50 | >50 |
| Tropisetron | >50 | >50 |
| Vemurafenib | >10 | NA |
| Zinc Pyrithione | >0.4 | NA |
Abbreviation: NA: not available to detect due to cytotoxicity.